MacroGenics Price to Free Cash Flow Ratio 2012-2025 | MGNX
Historical price to free cash flow ratio values for MacroGenics (MGNX) since 2012.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| MacroGenics Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-06-13 | 1.52 | 0.00 | |
| 2025-03-31 | 1.27 | $-1.15 | 0.00 |
| 2024-12-31 | 3.25 | $-1.15 | 0.00 |
| 2024-09-30 | 3.29 | $-0.99 | 0.00 |
| 2024-06-30 | 4.25 | $-2.52 | 0.00 |
| 2024-03-31 | 14.72 | $-1.83 | 0.00 |
| 2023-12-31 | 9.62 | $-1.29 | 0.00 |
| 2023-09-30 | 4.66 | $-0.35 | 0.00 |
| 2023-06-30 | 5.35 | $0.06 | 94.52 |
| 2023-03-31 | 7.17 | $-0.72 | 0.00 |
| 2022-12-31 | 6.71 | $-1.47 | 0.00 |
| 2022-09-30 | 3.46 | $-2.90 | 0.00 |
| 2022-06-30 | 2.95 | $-2.99 | 0.00 |
| 2022-03-31 | 8.81 | $-2.95 | 0.00 |
| 2021-12-31 | 16.05 | $-2.50 | 0.00 |
| 2021-09-30 | 20.94 | $-1.79 | 0.00 |
| 2021-06-30 | 26.86 | $-1.89 | 0.00 |
| 2021-03-31 | 31.85 | $-1.84 | 0.00 |
| 2020-12-31 | 22.86 | $-2.25 | 0.00 |
| 2020-09-30 | 25.19 | $-2.85 | 0.00 |
| 2020-06-30 | 27.92 | $-2.87 | 0.00 |
| 2020-03-31 | 5.82 | $-3.11 | 0.00 |
| 2019-12-31 | 10.88 | $-2.88 | 0.00 |
| 2019-09-30 | 12.76 | $-2.83 | 0.00 |
| 2019-06-30 | 16.97 | $-3.43 | 0.00 |
| 2019-03-31 | 17.98 | $-3.81 | 0.00 |
| 2018-12-31 | 12.70 | $-4.35 | 0.00 |
| 2018-09-30 | 21.44 | $-0.82 | 0.00 |
| 2018-06-30 | 20.65 | $-0.91 | 0.00 |
| 2018-03-31 | 25.16 | $-0.60 | 0.00 |
| 2017-12-31 | 19.00 | $-0.42 | 0.00 |
| 2017-09-30 | 18.48 | $-4.01 | 0.00 |
| 2017-06-30 | 17.51 | $-1.64 | 0.00 |
| 2017-03-31 | 18.60 | $-1.63 | 0.00 |
| 2016-12-31 | 20.44 | $-1.59 | 0.00 |
| 2016-09-30 | 29.91 | $-1.58 | 0.00 |
| 2016-06-30 | 26.99 | $-3.24 | 0.00 |
| 2016-03-31 | 18.75 | $-3.07 | 0.00 |
| 2015-12-31 | 30.97 | $-0.72 | 0.00 |
| 2015-09-30 | 21.42 | $-0.68 | 0.00 |
| 2015-06-30 | 37.97 | $-0.87 | 0.00 |
| 2015-03-31 | 31.37 | $-0.19 | 0.00 |
| 2014-12-31 | 35.07 | $-1.33 | 0.00 |
| 2014-09-30 | 20.90 | $-3.02 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.098B | $0.150B |
| MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.401B | 28.55 |
| Boston Scientific (BSX) | United States | $145.814B | 36.50 |
| Stryker (SYK) | United States | $145.229B | 30.37 |
| EssilorLuxottica (ESLOY) | France | $130.605B | 0.00 |
| Medtronic (MDT) | Ireland | $113.492B | 16.09 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.916B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.556B | 28.23 |
| ResMed (RMD) | United States | $36.981B | 27.78 |
| Agilent Technologies (A) | United States | $33.778B | 22.02 |
| GE HealthCare Technologies (GEHC) | United States | $33.476B | 15.89 |
| Terumo (TRUMY) | Japan | $27.213B | 35.35 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.367B | 83.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.451B | 11.85 |
| Baxter (BAX) | United States | $16.093B | 12.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.187B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.325B | 22.01 |
| Lantheus Holdings (LNTH) | United States | $5.545B | 13.99 |
| Prestige Consumer Healthcare (PBH) | United States | $4.207B | 18.80 |
| Perrigo (PRGO) | Ireland | $3.746B | 9.49 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.428B | 15.61 |
| ICU Medical (ICUI) | United States | $3.258B | 24.02 |
| Envista Holdings (NVST) | United States | $3.198B | 26.58 |
| GN Store Nord (GNNDY) | Denmark | $2.319B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.021B | 13.90 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.10 |
| AtriCure (ATRC) | United States | $1.600B | 0.00 |
| Acuren (TIC) | United States | $1.308B | 0.00 |
| Neogen (NEOG) | United States | $1.220B | 15.61 |
| AdaptHealth (AHCO) | United States | $1.187B | 12.05 |
| BioLife Solutions (BLFS) | United States | $1.107B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.061B | 23.86 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.963B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 8.95 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.656B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.637B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.576B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.419B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.92 |
| Aurora Cannabis (ACB) | Canada | $0.342B | 60.90 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.60 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanara MedTech (SMTI) | United States | $0.255B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Biote (BTMD) | United States | $0.216B | 6.08 |
| Brainsway (BWAY) | Israel | $0.216B | 57.10 |
| TriSalus Life Sciences (TLSI) | United States | $0.208B | 0.00 |
| Omeros (OMER) | United States | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 16.51 |
| Jin Medical (ZJYL) | China | $0.109B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.29 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |